Log In
Print
BCIQ
Print
Print this Print this
 

Onglyza, saxagliptin (BMS-477118)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionOral dipeptidyl peptidase-4 (DPP-4) inhibitor
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase (DPP) inhibitor
Latest Stage of DevelopmentMarketed
IndicationDiabetes
Partner

AstraZeneca plc; Kyowa Hakko Kirin Co. Ltd.; Otsuka Pharmaceutical Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today